Drug · DIN 02457121
BISMUTH CAPLETS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 16, 2026; first marketed September 28, 2018.
- Drug Identification Number (DIN)
- 02457121
- Company (DIN owner)
- LSL MedPlus Inc.Boucherville, Quebec, Canada
- Schedule
- Non-prescription drugs
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bismuth preparations A07BB
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BISMUTH SUBSALICYLATE | 262 MG |
Other DINs named BISMUTH CAPLETS
- DIN 02243123 · Cancelled Post Market
- DIN 02245730 · Dormant
- DIN 02280019 · Approved
- DIN 02418584 · Cancelled Post Market